Skip to main content
AHR logo

AHR · American Healthcare REIT, Inc. · Metrics

Track AHR — free
$51.26 -0.82 (-1.57%) At close · Sep 30
Ex-dividend: $0.25 · Sep 30, 2026 Return incl. dividend (before tax) -1.09%
Market Cap
$11.29B
Shares
218.00M
Volume · Sep 30 3.15M Avg daily vol (3M) 2.96M

AHR metrics

36 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$51.26
Market cap
$11.29B

Price action

20 metrics
Price change (1W)
+0.8%
Price change (30D)
-5.7%
Price change (3M)
-0.1%
Price change (6M)
+10.4%
Price change (YTD)
+10.7%
Price change (1Y)
+24.6%
Trailing year
Price change (5Y)
—
52-week high
$57.72
52-week low
$40.18
Change from 52-week high
-9.8%
Change from 52-week low
+29.6%
Annualized volatility
25.8%
Annualized volatility (3M)
25.3%
Beta
0.0
RSI (14D)
38.1
Price vs SMA 50
-4.9%
Price vs SMA 200
+2.2%
Avg volume (3M)
2.99M
Relative volume
0.9
Average dollar volume
$162.86M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
218.00M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.5%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.25
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
575
13F filer change QoQ
+53
Institutional ownership
103.5%

Short interest

3 metrics
Short interest
11.4%
Latest settlement · 9.3 days to cover
Days to cover
9.3d
Short-squeeze score
80 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$188,870
Insider-sentiment score
56 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1632970 CUSIP 398182303 13F (30d) 14 filings 12 filers Visit website